SCHEMBL31023263

SCHEMBL31023263

CCNc1cccc(C=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.45
ALDH1A1 P00352 3/20 0.44
UNG P13051 1/20 0.40
DRD2 P14416 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
DRD3 P35462 1/20 0.38
MAPT P10636 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
MAOA P21397 3/20 0.38
MAOB P27338 3/20 0.38
CYP2A6 P11509 1/20 0.38
LMNA P02545 1/20 0.38
EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5538035 1.00 HTR7 (0.45) HTR7ALDH1A1UNGDRD2DRD1
SCHEMBL5540240 0.85 HTR7 (0.49) HTR7ALDH1A1UNGDRD2DRD1
SCHEMBL5915750 0.82 HTR7 (0.53) HTR7ALDH1A1DRD2DRD1DRD4
SCHEMBL6187008 0.81 DRD1 (0.44) ALDH1A1DRD1MAPTLMNAALDH1A3
SCHEMBL9101071 0.81 HTR7 (0.52) HTR7ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL7024378 0.81 TP53 (0.48) HTR7ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL7285414 0.80 HTR7 (0.51) HTR7ALDH1A1MAPTCYP1A2CYP3A4
SCHEMBL3363357 0.79 MAPT (0.50) ALDH1A1MAPTCYP1A2CYP3A4CYP2D6
SCHEMBL11067660 0.78 HTR7 (0.43) HTR7ALDH1A1UNGMAPTHTT
SCHEMBL95532 0.78 ALDH1A1 (0.48) HTR7ALDH1A1UNGMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240299400-A1 Transcription Factor GLI1 Inhibitors and Uses Thereof UNIVERSITY OF CONNECTICUT (US) 2024-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240299400-A1 Transcription Factor GLI1 Inhibitors and Uses Thereof GLI1, GLI2, SHH HTR7 4045/4885ALDH1A1 550/4885UNG 4269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.